Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 331

    1.

    Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4{Delta}30-4995 in healthy adult volunteers.

    Wright PF, Durbin AP, Whitehead SS, Ikizler MR, Henderson S, Blaney JE, Thumar B, Ankrah S, Rock MT, McKinney BA, Murphy BR, Schmidt AC.

    Am J Trop Med Hyg. 2009 Nov;81(5):834-41.PMID: 19861619 [PubMed - indexed for MEDLINE]Related articles

    2.

    Progress towards a dengue vaccine.

    Webster DP, Farrar J, Rowland-Jones S.

    Lancet Infect Dis. 2009 Nov;9(11):678-87. Review.PMID: 19850226 [PubMed - indexed for MEDLINE]Related articles

    3.

    Diagnostics and discovery in viral hemorrhagic fevers.

    Lipkin WI, Palacios G, Briese T.

    Ann N Y Acad Sci. 2009 Sep;1171 Suppl 1:E6-11.PMID: 19751404 [PubMed - indexed for MEDLINE]Related articles

    4.

    Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.

    de la Torre JC.

    Ann N Y Acad Sci. 2009 Sep;1171 Suppl 1:E57-64.PMID: 19751403 [PubMed - indexed for MEDLINE]Related articles

    5.

    Changing patterns of dengue epidemiology and implications for clinical management and vaccines.

    Simmons CP, Farrar J.

    PLoS Med. 2009 Sep;6(9):e1000129. Epub 2009 Sep 1. No abstract available. PMID: 19721698 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Molecular and serologic markers of acute dengue infection in naive and flavivirus-vaccinated travelers.

    Domingo C, de Ory F, Sanz JC, Reyes N, Gascón J, Wichmann O, Puente S, Schunk M, López-Vélez R, Ruiz J, Tenorio A.

    Diagn Microbiol Infect Dis. 2009 Sep;65(1):42-8.PMID: 19679234 [PubMed - indexed for MEDLINE]Related articles

    7.

    Development of a RVFV ELISA that can distinguish infected from vaccinated animals.

    McElroy AK, Albariño CG, Nichol ST.

    Virol J. 2009 Aug 13;6:125.PMID: 19678951 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.

    Khanam S, Pilankatta R, Khanna N, Swaminathan S.

    Vaccine. 2009 Oct 9;27(43):6011-21. Epub 2009 Aug 7.PMID: 19665609 [PubMed - indexed for MEDLINE]Related articles

    9.

    Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine.

    Richardson JS, Yao MK, Tran KN, Croyle MA, Strong JE, Feldmann H, Kobinger GP.

    PLoS One. 2009;4(4):e5308. Epub 2009 Apr 23.PMID: 19390586 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.

    Geisbert TW, Geisbert JB, Leung A, Daddario-DiCaprio KM, Hensley LE, Grolla A, Feldmann H.

    J Virol. 2009 Jul;83(14):7296-304. Epub 2009 Apr 22.PMID: 19386702 [PubMed - indexed for MEDLINE]Related articles

    11.

    Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule.

    Sullivan NJ, Martin JE, Graham BS, Nabel GJ.

    Nat Rev Microbiol. 2009 May;7(5):393-400. Review. Erratum in: Nat Rev Microbiol. 2009 Sep;7(9):684. PMID: 19369954 [PubMed - indexed for MEDLINE]Related articles

    12.

    Attenuated D2 16681-PDK53 vaccine: defining humoral and cell-mediated immunity.

    Rabablert J, Yoksan S.

    Curr Pharm Des. 2009;15(11):1203-11. Review.PMID: 19355961 [PubMed - indexed for MEDLINE]Related articles

    13.

    Experimental vaccine may have saved Hamburg scientist from Ebola fever.

    Tuffs A.

    BMJ. 2009 Mar 23;338:b1223. doi: 10.1136/bmj.b1223. No abstract available. PMID: 19307268 [PubMed - indexed for MEDLINE]Related articles

    14.

    Dengue: recent advances in biology and current status of translational research.

    Swaminathan S, Khanna N.

    Curr Mol Med. 2009 Mar;9(2):152-73. Review.PMID: 19275624 [PubMed - indexed for MEDLINE]Related articles

    15.

    Pathogenesis and prevention of dengue virus infection: state-of-the-art.

    Tan GK, Alonso S.

    Curr Opin Infect Dis. 2009 Jun;22(3):302-8. Review.PMID: 19262377 [PubMed - indexed for MEDLINE]Related articles

    16.

    Dengue and dengue haemorrhagic fever: Indian perspective.

    Chaturvedi UC, Nagar R.

    J Biosci. 2008 Nov;33(4):429-41. Review.PMID: 19208969 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Evaluation of interferences between dengue vaccine serotypes in a monkey model.

    Guy B, Barban V, Mantel N, Aguirre M, Gulia S, Pontvianne J, Jourdier TM, Ramirez L, Gregoire V, Charnay C, Burdin N, Dumas R, Lang J.

    Am J Trop Med Hyg. 2009 Feb;80(2):302-11.PMID: 19190230 [PubMed - indexed for MEDLINE]Related articles

    18.

    Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs.

    Lagerqvist N, Näslund J, Lundkvist A, Bouloy M, Ahlm C, Bucht G.

    Virol J. 2009 Jan 17;6:6.PMID: 19149901 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Fever, headache, and myalgias after deployment to the Philippines.

    Trayers FJ 3rd, Simon J, Praske SP, Christopher KL.

    Mil Med. 2008 Dec;173(12):1188-93.PMID: 19149337 [PubMed - indexed for MEDLINE]Related articles

    20.

    Dengue-yellow fever sera cross-reactivity; challenges for diagnosis.

    Houghton-Triviño N, Montaña D, Castellanos J.

    Rev Salud Publica (Bogota). 2008 Mar-May;10(2):299-307.PMID: 19039426 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...